Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
TG Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.35
01.03.23
€22.48
01.03.24
15.57%
02.03.24

HC Wainwright 
01.03.23 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€40.60
01.03.23
€54.33
01.03.24
63.79%
02.03.24

Needham & Company LLC 
01.03.23 50%
buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€40.00
01.03.23
€71.20
01.03.24
-34.50%
02.03.24

Royal Bank of Canada 
01.03.23 50%
sell
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.19
22.02.24
-
22.02.25
-10.80%
02.03.24

Nicheplayer
Risky Investment
kostojunior 
22.02.24 0%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€22.48
31.01.24
-
29.02.24
230.87%
01.03.24

MBU 
31.01.24 50%
buy
SCYNEXIS Inc.

Start price
Target price
Perf. (%)
€1.74
28.02.23
-
28.02.24
-11.43%
29.02.24

Guggenheim 
28.02.23 50%
buy
Pacira Pharmaceuticals

Start price
Target price
Perf. (%)
€40.40
28.02.23
€56.63
28.02.24
-32.18%
29.02.24

Needham & Company LLC 
28.02.23 50%
buy
Krystal Biotech

Start price
Target price
Perf. (%)
€77.50
28.02.23
€95.04
28.02.24
93.55%
29.02.24

Guggenheim 
28.02.23 50%
buy
Prothena Corp. plc

Start price
Target price
Perf. (%)
€53.02
28.02.23
€67.71
28.02.24
-49.45%
29.02.24

Citigroup Inc. 
28.02.23 50%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€1.95
28.02.23
-
28.02.24
41.64%
29.02.24

StockNews.com 
28.02.23 50%
buy
Addus Homecare Corp.

Start price
Target price
Perf. (%)
€100.00
28.02.23
-
28.02.24
-16.50%
29.02.24

StockNews.com 
28.02.23 50%
buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.97
27.02.23
€15.12
27.02.24
-63.50%
28.02.24

Wedbush 
27.02.23 50%
buy
Natural Alternat.

Start price
Target price
Perf. (%)
€8.40
26.02.23
-
26.02.24
-35.12%
27.02.24

StockNews.com 
26.02.23 50%
buy
Pro-Dex Inc.

Start price
Target price
Perf. (%)
€14.00
26.02.23
-
26.02.24
7.86%
27.02.24

StockNews.com 
26.02.23 50%
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€58.60
24.06.23
€90.00
30.06.26
18.43%
19.02.24

Could be very worthwhile Investment >20% year
BiotechBee 
24.06.23 70%
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.18
02.12.23
€0.35
02.12.24
-28.97%
17.02.24

Could be very worthwhile Investment >20% year
BiotechBee 
02.12.23 50%
buy
Genfit S.A.

Start price
Target price
Perf. (%)
€3.32
10.12.23
€4.90
31.05.25
5.43%
17.02.24

Could be very worthwhile Investment >20% year
BiotechBee 
10.12.23 50%
buy
Cymabay Therapeutics Inc

Start price
Target price
Perf. (%)
€15.70
12.11.23
€20.00
31.03.26
89.81%
17.02.24

Could be very worthwhile Investment >20% year
BiotechBee 
12.11.23 70%
sell
Coherus Bioscien.

Start price
Target price
Perf. (%)
€1.88
05.02.24
-
05.02.25
33.90%
17.02.24

Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
kostojunior 
05.02.24 0%
buy
MicroVision Inc

Start price
Target price
Perf. (%)
€5.08
06.06.23
-
06.06.24
-55.66%
15.02.24

Dirk1 
06.06.23 50%
sell
Inovio Pharma

Start price
Target price
Perf. (%)
€1.47
13.02.23
€0.30
13.02.24
-63.81%
14.02.24

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
13.02.23 50%
buy
Aceragen Inc.

Start price
Target price
Perf. (%)
€1.52
02.05.23
€3.00
02.05.24
-70.66%
13.02.24

Could be worthwhile Investment >10% per year
melinda 
02.05.23 20%
sell
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.32
05.02.24
-
05.02.25
-43.81%
08.02.24

Good culture
Risky Investment
No uniques
me8 
05.02.24 0%
buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.35
05.02.24
-
05.02.25
29.34%
06.02.24

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques
me8 
05.02.24 0%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€75.00
21.01.24
-
21.01.25
-2.67%
03.02.24

Could be worthwhile Investment >10% per year
thomasw 
21.01.24 50%